126 related articles for article (PubMed ID: 30392698)
1. Acquisition of Inv(16)(p13q22) in a blast crisis of chronic myeloid leukemia: case report.
Oñate G; Blanco ML; Pratcorona M
Med Clin (Barc); 2019 May; 152(10):419-420. PubMed ID: 30392698
[No Abstract] [Full Text] [Related]
2. Fulminant blast crisis with de novo 11q23 rearrangement in a Philadelphia-positive CML patient undergoing treatment with dasatinib.
Janjetovic S; Asemissen AM; Dicker F; Binder M; Dierlamm J; Bokemeyer C; Schafhausen P
Tumori; 2019 Dec; 105(6):NP8-NP11. PubMed ID: 30935343
[TBL] [Abstract][Full Text] [Related]
3. The beauty and the beast: lymphoma-like morphology of myeloid blast phase in CML.
Asemissen AM; Dierlamm J
Blood; 2017 Sep; 130(10):1274. PubMed ID: 28882836
[No Abstract] [Full Text] [Related]
4. Coexistence of inversion 16 and the Philadelphia chromosome comprising P190 BCR/ABL in chronic myeloid leukemia blast crisis.
Ninomiya S; Kanemura N; Tsurumi H; Kasahara S; Hara T; Yamada T; Moriwaki H
Int J Hematol; 2011 Jun; 93(6):806-810. PubMed ID: 21523337
[TBL] [Abstract][Full Text] [Related]
5. Possible implication of IKAROS gene deletion and BCR-ABL1 variants in progression of chronic myeloid leukemia to lymphoid blast crisis in childhood: a single-institution experience.
Moschovi M; Adamaki M; Athanasiadou A; Divane A; Karytianou A; Tourkantoni N
Leuk Lymphoma; 2015; 56(8):2460-2. PubMed ID: 25641431
[No Abstract] [Full Text] [Related]
6. inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases.
Merzianu M; Medeiros LJ; Cortes J; Yin C; Lin P; Jones D; Glassman A; Kantarjian H; Huh Y
Am J Clin Pathol; 2005 Nov; 124(5):807-14. PubMed ID: 16203287
[TBL] [Abstract][Full Text] [Related]
7. Pediatric chronic myeloid leukemia with myeloid blast crisis and complex karyotype at presentation.
Sazawal S; Singh K; Chhikara S; Chaubey R; Mishra P; Seth T; Saxena R
Indian J Cancer; 2020; 57(3):343-345. PubMed ID: 32769290
[No Abstract] [Full Text] [Related]
8. [Research advance on molecular genetics of CML blast crisis].
Zhu HQ; Zhang S; Liu XL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):217-21. PubMed ID: 18315935
[TBL] [Abstract][Full Text] [Related]
9. BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial clone.
Behrens YL; Schienke A; Davenport C; Lentes J; Tauscher M; Steinemann D; Rasche M; Knirsch S; Joachim S; Reinhardt D; Schlegelberger B; Göhring G
Cancer Genet; 2021 Jun; 254-255():70-74. PubMed ID: 33647814
[TBL] [Abstract][Full Text] [Related]
10. Does eventually NPM1 mutation in blast phase chronic myeloid leukemia (BP-CML) exist? That is the question.
Henry A; Bracquemart C; Naguib D; Chantepie S; Cheze S; Johnson-Ansah HA
Br J Haematol; 2021 Nov; 195(3):469-471. PubMed ID: 34396510
[No Abstract] [Full Text] [Related]
11. BCR/ABL amplification in chronic myelocytic leukemia blast crisis following imatinib mesylate administration.
Campbell LJ; Patsouris C; Rayeroux KC; Somana K; Januszewicz EH; Szer J
Cancer Genet Cytogenet; 2002 Nov; 139(1):30-3. PubMed ID: 12547154
[TBL] [Abstract][Full Text] [Related]
12. Clinical and genetic studies of ETV6/ABL1-positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylate.
Barbouti A; Ahlgren T; Johansson B; Höglund M; Lassen C; Turesson I; Mitelman F; Fioretos T
Br J Haematol; 2003 Jul; 122(1):85-93. PubMed ID: 12823349
[TBL] [Abstract][Full Text] [Related]
13. An uncommon case of chronic myeloid leukemia with variant cytogenetic.
Abdullah MA; Amer A; Nawaz Z; Abdullah AS; Al-Sabbagh A; Kohla S; Nashwan AJ; Yassin MA
Acta Biomed; 2018 Apr; 89(3-S):28-32. PubMed ID: 29633730
[TBL] [Abstract][Full Text] [Related]
14. Patterns of BCR breakpoints in patients with coexisting inv(16)(p13.1q22) and t(9;22)(q34;q11.2).
Bustamante D; Chan KR; Czuchlewski DR; Saadi AA
Int J Hematol; 2012 Mar; 95(3):324-6. PubMed ID: 22370710
[No Abstract] [Full Text] [Related]
15. The prognostic significance of an inv(3)(q21q26.2) in addition to a t(9;22)(q34;q11.2) in patients treated with tyrosine kinase inhibitors.
Theil KS; Cotta CV
Cancer Genet; 2014 May; 207(5):171-6. PubMed ID: 25027637
[TBL] [Abstract][Full Text] [Related]
16. Clonal evolution of AML1-ETO coexisting with BCR-ABL and additional chromosome abnormalities in a blastic transformation of chronic myeloid leukemia.
Ma CC; Chai Y; Chen HL; Wang X; Gao Y; Hu WL; Xiang X
J Int Med Res; 2020 May; 48(5):300060520919237. PubMed ID: 32366154
[TBL] [Abstract][Full Text] [Related]
17. Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy.
Haaß W; Kleiner H; Weiß C; Haferlach C; Schlegelberger B; Müller MC; Hehlmann R; Hofmann WK; Fabarius A; Seifarth W; ;
PLoS One; 2015; 10(6):e0129648. PubMed ID: 26087013
[TBL] [Abstract][Full Text] [Related]
18. Extramedullary blast crisis derived from 2 different clones in the central nervous system and neck during complete cytogenetic remission of chronic myelogenous leukemia treated with imatinib mesylate.
Matsuda M; Morita Y; Shimada T; Miyatake J; Hirase C; Tanaka M; Tatsumi Y; Maeda Y; Kanamaru A
Int J Hematol; 2005 May; 81(4):307-9. PubMed ID: 15914360
[TBL] [Abstract][Full Text] [Related]
19. Acute myelomonocytic leukemia with inv(16)(p13q22) complicating Philadelphia chromosome positive chronic myeloid leukemia.
Heim S; Christensen BE; Fioretos T; Sørensen AG; Pedersen NT
Cancer Genet Cytogenet; 1992 Mar; 59(1):35-8. PubMed ID: 1555189
[TBL] [Abstract][Full Text] [Related]
20. Promyelocytic Blastic Crisis in Chronic Myeloid Leukemia During Imatinib Treatment.
Angriman F; Gutierrez Acevedo MN; Rossi MS; Gimenez Conca AD; Otero V; Arbelbide JA; Michelángelo H
Turk J Haematol; 2015 Jun; 32(2):193-4. PubMed ID: 26316496
[No Abstract] [Full Text] [Related]
[Next] [New Search]